Al-Dahshan Ayman, Hammoud Hamed, Chehab Mohamad, Osman Sherif R Omar
Community Medicine Residency Program, Hamad Medical Corporation, Doha, Qatar.
Family and Community Medicine, Primary Health Care Corporation, Doha, Qatar.
Qatar Med J. 2019 Jul 25;2019(1):4. doi: 10.5339/qmj.2019.4. eCollection 2019.
Vaccination is considered one of the most successful and cost-effective public health interventions of the 20 century. In 2017, Qatar's Expanded Program of Immunization (EPI) provided vaccination services against a comprehensive list of 15 vaccine-preventable diseases. To assess the performance of Qatar's national immunization system, identify possible gaps by determining the national vaccination coverage rates, and benchmark these rates against regional and global figures. The data utilized herein were retrieved from the vaccination coverage estimates generated by the World Health Organization and United Nations International Children's Emergency Fund. Relevant local, regional, and global vaccination coverage figures were manually extracted and then analyzed for six vaccines (DTP3, Pol3, MCV2, HepB, PCV3, and RotaC) in 2017. Percentages and proportions were compared using the Chi-squared test. Vaccination coverage levels in Qatar have surpassed the optimal level of 90% for all vaccines. Compared with international figures, the national coverage exceeds the relevant benchmarks. For DTP3 and Pol3, Qatar achieved 97% coverage compared with 99% coverage in Jordan and 85% coverage globally. For MCV2, Qatar achieved 93% coverage compared with 99% coverage in Jordan and 67% coverage globally. For RotaC, Qatar achieved 97% coverage compared with 96% coverage in Jordan and 28% coverage globally. For HepB, Qatar achieved 97% coverage compared with 43% coverage globally. Compared with the international benchmarks of major vaccines, the vaccination coverage rates in Qatar are high. However, challenges for maintaining high coverage, such as cultural and language barriers, should be addressed.
疫苗接种被认为是20世纪最成功且最具成本效益的公共卫生干预措施之一。2017年，卡塔尔扩大免疫规划（EPI）针对15种疫苗可预防疾病的综合清单提供了疫苗接种服务。为评估卡塔尔国家免疫体系的绩效，通过确定国家疫苗接种覆盖率来找出可能存在的差距，并将这些覆盖率与区域和全球数据进行基准对比。本文所使用的数据取自世界卫生组织和联合国儿童基金会生成的疫苗接种覆盖率估计值。手动提取了相关的本地、区域和全球疫苗接种覆盖率数据，然后对2017年的六种疫苗（三联疫苗第三剂、脊髓灰质炎疫苗第三剂、脑膜炎球菌结合疫苗第二剂、乙型肝炎疫苗、肺炎球菌结合疫苗第三剂和轮状病毒疫苗）进行了分析。使用卡方检验比较百分比和比例。卡塔尔所有疫苗的接种覆盖率均超过了90%的最佳水平。与国际数据相比，该国的覆盖率超过了相关基准。对于三联疫苗第三剂和脊髓灰质炎疫苗第三剂，卡塔尔的接种覆盖率为97%，而约旦为99%，全球为85%。对于脑膜炎球菌结合疫苗第二剂，卡塔尔的接种覆盖率为93%，而约旦为99%，全球为67%。对于轮状病毒疫苗，卡塔尔的接种覆盖率为97%，而约旦为96%，全球为28%。对于乙型肝炎疫苗，卡塔尔的接种覆盖率为97%，而全球为43%。与主要疫苗的国际基准相比，卡塔尔的疫苗接种覆盖率较高。然而，应应对维持高覆盖率所面临的挑战，如文化和语言障碍。
